A5004329876- Heparin-Induced Thrombocytopenia and Thrombosis
- Platelet Disorders and Treatments
- Biosimilars and Bioanalytical Methods
- Chemical Reactions and Isotopes
- 3D Printing in Biomedical Research
- SARS-CoV-2 and COVID-19 Research
- Antimicrobial Resistance in Staphylococcus
- Monoclonal and Polyclonal Antibodies Research
- Protein purification and stability
- Venous Thromboembolism Diagnosis and Management
- Viral Infections and Immunology Research
- Mass Spectrometry Techniques and Applications
- Innovative Microfluidic and Catalytic Techniques Innovation
- Vaccine Coverage and Hesitancy
- Antimicrobial Peptides and Activities
- Intramuscular injections and effects
- Cell Image Analysis Techniques
- Bacterial biofilms and quorum sensing
European Medicines Agency
2022-2024
Janssen (Netherlands)
2021
Following the start of COVID-19 vaccination campaign, adverse events myocarditis and pericarditis were linked mainly to mRNA vaccines by regulatory authorities worldwide. have been administered several million people risk post has characterised in great detail. At present time research data available are scarce there is still no clear understanding biological mechanism/s responsible for this disease. This manuscript provides a concise overview epidemiology most prominent mechanistic insights...
Safety and efficacy of vaccines against the SARS-CoV-2 coronavirus has been demonstrated in clinical trials next by their real world use through course ongoing COVID-19 pandemic. However, very rare adverse events have detected post-authorization certain parts world. This meeting report summarizes an EMA workshop's discussion on epidemiology, presentation biology thrombosis with thrombocytopenia syndrome after adenovirus vector vaccination. General agreement was reached international...
The 17
The 18th Workshop on Recent Issues in Bioanalysis (18th WRIB) took place San Antonio, TX, USA May 6-10, 2024. Over 1100 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies convened to actively discuss the most current topics of interest bioanalysis. WRIB included 3 Main Workshops 7 Specialized that together spanned 1 week allow an exhaustive thorough coverage all major issues bioanalysis biomarkers, immunogenicity, gene therapy, cell therapy vaccines....
The urgency and importance of organizing a global effort to harmonize clinical assay validation specific the vaccine industry was identified during drafting 2020 White Paper in Bioanalysis due lack clarity regulatory guidance/guidelines immunoassay validation. Indeed, Workshop on Recent Issues (WRIB) issues yearly, which is one high-profile articles Journal focused detailed discussions recommendations Since 2017, participation WRIB working groups by experts regulators has rapidly increased...
Abstract Vaccines against Staphylococcus aureus have eluded researchers for >3 decades while the burden of staphylococcal diseases has increased. Early vaccine attempts mainly used rodents to characterize preclinical efficacy, and all subsequently failed in human clinical efficacy trials. More recently, leukocidin AB (LukAB) gained interest as a antigen. We developed minipig deep surgical wound infection model offering 3 independent readouts: bacterial load at superficial deep-seated...